Fingerprint
Dive into the research topics of 'Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically